These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26214558)

  • 1. Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution.
    Kelly S; Su Y
    Intellect Dev Disabil; 2015 Aug; 53(4):289-300. PubMed ID: 26214558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records.
    Lott IT; McGregor M; Engelman L; Touchette P; Tournay A; Sandman C; Fernandez G; Plon L; Walsh D
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):563-71. PubMed ID: 15312057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
    Christian L; Snycerski SM; Singh NN; Poling A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
    Martin JE; Agran M
    Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
    Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
    J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of a psychiatric service in a long-term charitable facility for people with intellectual disabilities: a 5-year medication survey.
    Ruggerini C; Guaraldi GP; Russo A; Neviani V; Castagnini A
    Res Dev Disabil; 2004; 25(5):431-41. PubMed ID: 15217672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.
    McLaren JL; Lichtenstein JD
    Epidemiol Psychiatr Sci; 2019 Aug; 28(4):365-368. PubMed ID: 30353794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in the Medication Management Process in People Who Have Intellectual and Developmental Disabilities: A Qualitative Study of the Caregivers' Perspective.
    Erickson SR; Salgado TM; Tan X
    Intellect Dev Disabil; 2016 Dec; 54(6):412-426. PubMed ID: 27893313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.